Equillium price target lowered to $4.50 from $5.50 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Equillium to $4.50 from $5.50 and keeps a Buy rating on the shares post the Q3 report. The analyst cites higher operating expenses going forward for the target drop.